Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

947
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
947
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

832
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

988
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
988
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

741
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
741
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

918
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
918
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

1.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Risk Stratification of Patients With Type 2 Long-QT Syndrome Through Analysis of T-Wave Morphology.

Journal of the American Heart Association·2026
Same author

Genotype-phenotype correlation of 139 p.Gln530Ter-KCNQ1 patients with inherited long QT syndrome.

Heart rhythm·2026
Same author

[Troponin elevation without myocardial injury - a diagnostic pitfall in cases of analytical interference].

Lakartidningen·2025
Same author

[»Occlusion Myocardial Infarction« (OMI) - a new classification proposed to improve detection beyond strict STEMI criteria].

Lakartidningen·2025
Same author

Plasma Trough Concentrations of Beta-Lactam Antibiotics in the Early Phase of Septic Shock.

Acta anaesthesiologica Scandinavica·2025
Same author

Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis.

Infection·2025

相关实验视频

Updated: Jun 28, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.7K

[高度的心房静脉 (AV) 阻塞]

Peter Hammarlund1, Erik Ljungström2, Daniel Bremell3

  • 1Specialistläkare, kardiologsektionen, Helsingborgs lasarett.

Lakartidningen
|April 10, 2024
PubMed
概括

年轻患者的高度心房静脉阻塞可能是由莱姆心炎引起的,这是一个可逆的疾病. 及时诊断和抗生素治疗可以防止不必要的心脏起器植入.

科学领域:

  • 心脏病学 心脏病学
  • 传染性疾病 传染性疾病
  • 电子生理学 电子生理学

背景情况:

  • 高度心房 (AV) 阻塞在老年人中通常是由于不可逆转的心脏导电系统退化.
  • 在植入心脏起器之前,必须排除AV阻塞的可逆原因,特别是在不寻常的病因更常见的年轻患者中.

研究的目的:

  • 突出莱姆心炎作为一种罕见但可逆的AV阻塞原因.
  • 强调在年轻和中年患者呈现高度AV阻塞时考虑莱姆心炎的重要性.

主要方法:

  • 文献综述专注于莱姆心炎和AV阻塞.
  • 对莱姆心炎的诊断标准和治疗结果的分析.
  • 评估血清学测试与临床表现的结合.

主要成果:

  • 莱姆心炎是莱姆病的表现,可以导致可逆的AV阻塞.
  • 在中等到高预测概率的患者中,Borrelia burgdorferi的阳性血清测试强烈表明莱姆心炎.
  • 抗生素治疗可以有效地逆转由莱姆心炎引起的导电障碍.

结论:

  • 在年轻人群体中对AV阻塞的差异诊断中应考虑莱姆心炎.

更多相关视频

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.6K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

14.7K

相关实验视频

Last Updated: Jun 28, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.7K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.6K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

14.7K
  • 早期诊断和莱姆心炎的抗生素治疗可以防止需要永久性起器植入.
  • 识别和治疗像莱姆心炎这样的可逆原因对于管理AV阻塞至关重要.